Additionally, obese patients with breast cancer displayed significantly higher FABP4 levels in serum, which were associated with larger tumor size and poorer prognosis, regardless of menopausal status (Hao et al., 2018a; Hao et al., 2018b). Here, FABP4 is linked to breast carcinoma.